Moderna and its partners in the federal government are just now gearing up for a late-stage COVID-19 vaccine trial set to launch later this month, but at the same ti...

Johnson & Johnson is battling giants in the immunology field with its IL-23 inhibitor Tremfya. With other next-gen drugs already crowding the market, J...

Bob Harper is back again in AstraZeneca’s cardiac survivor awareness effort. AZ re-signed the fitness guru and TV personality, who famously survived a near-fatal hea...

Novartis' blockbuster Entresto missed a big opportunity last year with a failed late-stage trial in certain heart failure patients without a current approved treatme...

July 8, 2020, Dusseldorf, Germany – MLM Medical Labs GmbH (“MLM”), a Great Point Partners (“GPP”) portfolio company, today announced the acquisition of CirQuest Labs...

Welsh rugby player Gareth Thomas knows what it feels like to be stigmatized. First, when he came out as gay more than 10 years ago, and more recently after he reveal...

AbbVie's Allergan and Evolus have been locked in a yearslong trade secrets fight involving the two drugmakers' South Korean partners and blockbuster Botox. Despite s...

As COVID-19 vaccines move into late-stage testing, governments and drugmakers are scrambling to secure packaging to store those shots. One Alabama-based materials ma...

Diabetes med metformin has been in the FDA's crosshairs since the agency found high levels of a probable carcinogen, NDMA, that had already triggered global recalls f...